US Government Spending on New Drugs With Incomplete and Postponed Mandatory Pediatric Trials
This cohort study estimates Medicare Part D, Medicaid, and Medicare Part B spending on pediatric drugs approved by the US Food and Drug Administration from 2015 to 2021.
Authors
- Ian T. T. Liu
- Aaron Seth Kesselheim (ORCID: https://orcid.org/0000-0002-8867-2666)
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
- University of Illinois Chicago (US)
- University of Chicago (US)
Publication Details
- Journal
- JAMA Pediatrics
- Published
- 2025-09-02
- DOI
- https://doi.org/10.1001/jamapediatrics.2025.2817
- Citations
- 1
- Primary Topic
- Pharmaceutical studies and practices
- Type
- article
- Field-Weighted Citation Impact
- 3.49